Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-042378

Chief Financial Officer sold 6,255 shares at an average $4.49 ($28,086)

From the SEC's structured data for this filing

Trades in this filing

Koppikar Utpal · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Sale : show line 1 in the form −5,172 $4.49 $23,222 192,417 D
2022-11-16 Sale : show line 2 in the form −1,083 $4.49 $4,864 191,334 D
Open-market sales · 6,255 sh · avg $4.49 · $28,086
Loading xslF345X03/form4.xml…